BRIEF-Medical Prognosis Institute and Oncology Venture enter three deals on DRP's

* Says has sold three Drug Response Predictors (DRPs) to Oncology Venture for three new

selected compounds combined with MPI'S DRP for anti-cancer treatment

Source text for Eikon:

Further company coverage:

(Gdynia Newsroom)

Read more